TrialClinical cancer research : an official journal of the American Association for Cancer Research2024

Paclitaxel plus Eftilagimod Alpha, a Soluble LAG-3 Protein, in Metastatic, HR+ Breast Cancer: Results from AIPAC, a Randomized, Placebo Controlled Phase IIb Trial.

Hans Wildiers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.